Keene, NH, United States of America

Karl L Hecker

This inventor holds 1 USPTO granted patent. Top assignee: Insite Vision Corporation. Active years: 2002.


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 176(Granted Patents)


Company Filing History:


Years Active: 2002

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Karl L Hecker

Introduction: Karl L Hecker is a notable inventor based in Keene, NH (US). He has made significant contributions to the field of ophthalmology through his innovative patent. His work focuses on improving the methods of administering therapeutic and diagnostic materials to the eye, particularly in the posterior segment.

Latest Patents: Karl L Hecker holds a patent for "Methods of ophthalmic administration." This patent describes an intrascleral injection technique that allows for a minimally invasive delivery of agents to the posterior segment of the eye. This method is particularly beneficial for treating conditions such as macular degeneration, vein occlusion, and diabetic retinopathy. He has 1 patent to his name, showcasing his commitment to advancing medical technology.

Career Highlights: Hecker's career is marked by his association with Insite Vision Corporation, where he has been able to apply his innovative ideas in a practical setting. His work has contributed to the development of new treatment options for patients suffering from serious eye conditions.

Collaborations: Throughout his career, Karl has collaborated with esteemed colleagues, including Lyle M Bowman and James Frederick Pfeiffer. These partnerships have allowed for the exchange of ideas and further advancements in the field of ophthalmology.

Conclusion: Karl L Hecker's contributions to ophthalmic administration represent a significant advancement in medical technology. His innovative methods provide new hope for patients with serious eye conditions, demonstrating the impact of dedicated inventors in the healthcare industry.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…